A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts.
Kawakami K, Hattori M, Inoue T, Maruyama Y, Ohkanda J, Kato N, Tongu M, Yamada T, Akimoto M, Takenaga K, Sassa T, Suzumiy J, Honma Y.
Kawakami K, et al. Among authors: honma y.
Anticancer Agents Med Chem. 2012 Sep;12(7):791-800. doi: 10.2174/187152012802650264.
Anticancer Agents Med Chem. 2012.
PMID: 22263802